BioCentury
ARTICLE | Company News

FDA to review grass allergy tablet

March 28, 2013 12:13 AM UTC

ALK-Abello A/S (CSE:ALK-B) and partner Merck & Co. Inc. (NYSE:MRK) said FDA accepted for review a BLA from Merck for grass Allergy Immunotherapy Tablet (AIT). Merck said it expects a decision on the a...